Search Results - "Mujtaba, Muhammad A."

Refine Results
  1. 1

    Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older by Mujtaba, Muhammad A., Gamilla-Crudo, Ann Kathleen, Merwat, Shehzad N., Hussain, Syed A., Kueht, Michael, Karim, Aftab, Khattak, Muhammad W., Rooney, Peggy J., Jamil, Khurram

    Published in Annals of hepatology (01-09-2023)
    “…Clinical data for older patients with advanced liver disease are limited. This post hoc analysis evaluated the efficacy and safety of terlipressin in patients…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Pancreas transplantation after bariatric surgery by Porubsky, Marian, Powelson, John A., Selzer, Don J., Mujtaba, Muhammad A., Taber, Tim, Carnes, Katerine L., Fridell, Jonathan A.

    Published in Clinical transplantation (01-01-2012)
    “…Porubsky M, Powelson JA, Selzer DJ, Mujtaba MA, Taber T, Carnes KL, Fridell JA. Pancreas transplantation after bariatric surgery. 
Clin Transplant 2012: 26:…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Early Steroid Withdrawal in Repeat Kidney Transplantation by Mujtaba, Muhammad A, Taber, Tim E, Goggins, William C, Yaqub, Muhammad S, Mishler, Dennis P, Milgrom, Martin L, Fridell, Jonathan A, Lobashevsky, Andrew, Powelson, John A, Sharfuddin, Asif A

    “…Kidney re-transplantation (KRT) candidates are considered at high risk for graft failure. Most of these patients are kept on a chronic steroid maintenance…”
    Get full text
    Journal Article
  6. 6

    A case series of perioperative anaphylaxis to cefazolin during kidney transplant and review of literature by Salehin, Salman, Kumar, Anand, Harsell, Nantian, Salim, Hamza, Hussain, Syed A., Kueht, Michael, Mujtaba, Muhammad A.

    Published in Transplant immunology (01-12-2022)
    “…Intraoperative anaphylaxis is a life threatening and multiorgan system hypersensitivity reaction that frequently leads to cessation of operations. Despite the…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Kidney Allograft Monitoring by Combining Donor-Derived Cell-Free DNA and Molecular Gene Expression: A Clinical Management Perspective by Rizvi, Asim, Faiz, Sara, Thakkar, Parin H, Hussain, Syed, Gamilla-Crudo, Ann N, Kueht, Michael, Mujtaba, Muhammad A

    Published in Journal of personalized medicine (29-07-2023)
    “…Donor-derived cell-free DNA (dd-cfDNA) may safely assess kidney allograft rejection. Molecular Microscope (MMDx®) gene expression may offer increased precision…”
    Get full text
    Journal Article
  11. 11

    Antibody Therapeutics as Interfering Agents in Flow Cytometry Crossmatch for Organ Transplantation by Kueht, Michael L, Dongur, Laxmi Priya, Mujtaba, Muhammad A, Cusick, Matthew F

    Published in Journal of personalized medicine (16-06-2023)
    “…Donor-recipient matching is a highly individualized and complex component of solid organ transplantation. Flowcytometry crossmatching (FC-XM) is an integral…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Analysis of Anti-HLA Antibodies in Sensitized Kidney Transplant Candidates Subjected to Desensitization with Intravenous Immunoglobulin and Rituximab by Lobashevsky, Andrew L, Higgins, Nancy G, Rosner, Kevin M, Mujtaba, Muhammad A, Goggins, William C, Taber, Tim E

    Published in Transplantation (27-07-2013)
    “…BACKGROUNDPreexisting donor-specific antibodies against human leukocyte antigens are major risk factors for acute antibody-mediated and chronic rejection of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Re-transplants compared to primary kidney transplants recipients: a mate kidney paired analysis of the OPTN/UNOS database by Khalil, Ali K., Slaven, James E., Mujtaba, Muhammad A., Yaqub, Muhammad S., Mishler, Dennis P., Taber, Tim E., Sharfuddin, Asif A.

    Published in Clinical transplantation (01-05-2016)
    “…Outcomes of kidney re‐transplant recipients (RTR) were compared to primary recipients (FTR) from paired donor kidneys. Organ Procurement and Transplantation…”
    Get full text
    Journal Article
  16. 16

    Pre-transplant angiotensin receptor II type 1 antibodies and risk of post-transplant focal segmental glomerulosclerosis recurrence by Mujtaba, Muhammad A., Sharfuddin, Asif A., Book, Benita L., Goggins, William C., Khalil, Ali A., Mishler, Dennis P., Fridell, Johnathan A., Yaqub, Muhammad S., Taber, Tim E.

    Published in Clinical transplantation (01-07-2015)
    “…Post‐kidney transplant recurrence of focal segmental glomerulosclerosis (FSGS) is a major problem. AT1R is expressed on podocyte; its expression is elevated in…”
    Get full text
    Journal Article
  17. 17

    Vascular catastrophes following pancreas transplantation: an evolution in strategy at a single center by Fridell, Jonathan A., Johnson, Matthew S., Goggins, William C., Beduschi, Thiago, Mujtaba, Muhammad A., Goble, Michelle L., Powelson, John A.

    Published in Clinical transplantation (01-01-2012)
    “…Fridell JA, Johnson MS, Goggins WC, Beduschi T, Mujtaba MA, Goble ML, Powelson JA. Vascular catastrophes following pancreas transplantation: an evolution in…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Late pancreas retransplantation by Fridell, Jonathan A., Mangus, Richard S., Chen, Jeanne M., Goble, Michelle L., Mujtaba, Muhammad A., Taber, Tim E., Powelson, John A.

    Published in Clinical transplantation (01-01-2015)
    “…Pancreas retransplantation, excluding immediate retransplantation for graft thrombosis, is a technically treacherous operation with the added challenges of…”
    Get full text
    Journal Article
  20. 20